Cell-free DNA screening and sex chromosome aneuploidies

Prenatal Diagnosis

Volumn 35, Issue 10, 2015, Pages 980-985

  Mennuti, Michael T ^a   Chandrasekaran, Suchitra ^b   Khalek, Nahla ^c   Dugoff, Lorraine ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

47,XXX SYNDROME; 47,XXY SYNDROME; 47,XYY SYNDROME; CELL FREE SYSTEM; DECISION MAKING; DNA DETERMINATION; DNA SCREENING; FETUS ECHOGRAPHY; GENETIC COUNSELING; HUMAN; KARYOTYPE 45,X; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEX CHROMOSOME ABERRATION; SEX DETERMINATION; ANEUPLOIDY; ETHICS; FEMALE; MATERNAL SERUM SCREENING TEST; PREGNANCY; SEX CHROMOSOME DISORDERS;

ANEUPLOIDY; FEMALE; GENETIC COUNSELING; HUMANS; MATERNAL SERUM SCREENING TESTS; PREGNANCY; SEX CHROMOSOME ABERRATIONS; SEX CHROMOSOME DISORDERS; SEX DETERMINATION ANALYSIS;

EID: 84943349710     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4639     Document Type: Review

References (43)

1. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14: 296-305.
2. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-20.
3. Canick JA, Palomaki GE, Kloza EM, et al. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat Diagn 2013;33:667-74.
4. Ashoor G, Syngelaki A, Wagner M, et al. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206: 322.e1-e5.
5. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
6. Norton ME, Brar H, Weiss J, et al. Non-invasive chromosomal evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137.e1-e8.
7. Sparks AB, Struble CA, Wang ET, et al. Optimized non-invasive evaluation of fetal aneuploidy risk using cell-free DNA from maternal blood. Am J Obstet Gynecol 2012;206:319.e1-e9.
8. Robinson A, Bender BG, Linden MG, Salbenblatt JA. Sex chromosome aneuploidy: the Denver Prospective Study. Birth Defects Orig Artic Ser 1990;26:59-115.
9. Robinson A, Bender BG, Linden MG. Decisions following the intrauterine diagnosis of sex chromosome aneuploidy. Am J Med Genet 1989;34:552-4.
10. Robinson A, Bender BG, Linden MG. Summary of clinical findings in children and young adults with sex chromosome anomalies. Birth Defects Orig Artic Ser 1990;26:225-8.
11. Robinson A, Bender BG, Linden MG. Prognosis of prenatally diagnosed children with sex chromosome aneuploidy. Am J Med Genet 1992;44: 365-8.
12. Hsu LY. Phenotype/karyotype correlations of Y chromosome aneuploidy with emphasis on structural aberrations in postnatally diagnosed cases. Am J Med Genet 1994;53:108-40.
13. Jacobs PA. The incidence and etiology of sex chromosome abnormalities in man. Birth Defects Orig Artic Ser 1979;15:3-14.
14. Ross JL, Roeltgen DP, Kushner H, et al. Behavioral and social phenotypes in boys with 47, XYY syndrome or 47, XXY Klinefelter syndrome. Pediatrics 2012;129:769-78.
15. Linden MG, Bender BG, Robinson A. Genetic counseling for sex chromosome abnormalities. Am J Med Genet 2002;110:3-10.
16. Rogol AD, Swerdloff RS, Reiter EO, et al. A multicenter, open-label, observational study of testosterone gel (1%) in the treatment of adolescent boys with Klinefelter syndrome or anorchia. J Adolesc Health 2014;54:20-5.
17. Linden MG, Bender BG. Fifty-one prenatally diagnosed children and adolescents with sex chromosome abnormalities. Am J Med Genet 2002; 110:11-8.
18. Ross JL, Quigley CA, Cao D, et al. Growth hormone plus childhood low-dose estrogen in Turner's syndrome. N Engl J Med 2011;364:1230-42.
19. Ross JL, Roeltgen D, Feuillan P, et al. Effects of estrogen on nonverbal processing speed and motor function in girls with Turner's syndrome. J Clin Endocrinol Metab 1998;83:3198-204.
20. Idem. Use of estrogen in young girls with Turner syndrome: effects on memory. Neurology 2000;54:164-70.
21. Wosnitzer MS, Paduch DA. Endocrinological issues and hormonal manipulation in children and men with Klinefelter syndrome. Am J Med Genet Part C, Semin Med Genet 2013;163C:16-26.
22. Radicioni AF, De Marco E, Gianfrilli D, et al. Strategies and advantages of early diagnosis in Klinefelter's syndrome. Mol Hum Reprod 2010;16: 434-40.
23. Bojesen A, Birkebaek N, Kristensen K, et al. Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int 2011;22:1441-50.
24. Mezei G, Papp C, Toth-Pal E, et al. Factors influencing parental decision making in prenatal diagnosis of sex chromosome aneuploidy. Obstet Gynecol 2004;104:94-101.
25. Gruchy N, Vialard F, Decamp M, et al. Pregnancy outcomes in 188 French cases of prenatally diagnosed Klinefelter syndrome. Hum Reprod 2011;26:2570-5.
26. Gruchy N, Vialard F, Blondeel E, et al. Pregnancy outcomes of prenatally diagnosed turner syndrome: a French multicenter retrospective study including a series of 975 cases. Prenat Diagn 2014;34:1133-8.
27. Shaw SW, Chueh HY, Chang SD, et al. Parental decisions regarding prenatally detected fetal sex chromosomal abnormality and the impact of genetic counselling: an analysis of 57 cases in Taiwan. Aust N Z J Obstet Gynaecol 2008;48:155-9.
28. Marteau TM, Nippert I, Hall S, et al. Outcomes of pregnancies diagnosed with Klinefelter syndrome: the possible influence of health professionals. Prenat Diagn 2002;22(7):562-6.
29. Hall S, Marteau TM, Limbert C, et.al. Counselling following the prenatal diagnosis of Klinefelter syndrome: comparisons between geneticists and obstetricians in five European countries. Community Genet 2001;4(4):233-8.
30. Park JP, Brothman AR, Butler MG, et al. Extensive analysis of mosaicism in a case of Turner syndrome: the experience of 287 cytogenetic laboratories. College of American Pathologist/American College of Medical Genetics Cytogenetics Resource Committee. Arch Pathol Lab Med 1999;123(5):381-5.
31. Délot EC, Vilain EJ. Nonsyndromic 46, XX testicular disorders of sex development. In GeneReviews® [Internet], Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K (eds). Seattle (WA): University of Washington, Seattle. 2015.
32. Yao H, Zhang L, Zhang H, et al. Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X. Prenat Diagn 2012;32(11): 1114-6.
33. Russell LM, Strike P, Browne CE, Jacobs PA. X chromosome loss and aging. Cytogenet Genome Res 2007;116(3):181-5.
34. Osborne CM, Hardisty E, Devers P, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn 2013;33:609-11.
35. Devaney SA, Palomaki GE, Scott JA, Bianchi DW. Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA 2011;306:627-36.
36. Mazloom AR, Dzakula Z, Oeth P, et al. Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat Diagn 2013;33:591-7.
37. Nicolaides KH, Musci TJ, Struble CA, et al. Assessment of fetal sex chromosome aneuploidy using directed cell-free DNA analysis. Fetal Diagn Ther 2014;35:1-6.
38. Bianchi DW, Parsa S, Bhatt S, et al. Fetal sex chromosome testing by maternal plasma DNA sequencing: clinical laboratory experience and biology. Obstet Gynecol 2015;125:375-82.
39. Wang J-C, Shaoo T, Schonberg S, et al. Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases. Genet Med 2015;17:234-6.
40. Dewald G, Stallard R, Saadi A, et al. A multicenter investigation with interphase fluorescence in situ hybridization using X and Y chromosome probes. Am J Med Genet 1998;70:318-26.
41. Lui YY, Chik KW, Chiu RW, et al. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 2002;48(3):421-7.
42. Chitty LS, Chatelain P, Wolffenbuttel KP, Aigrain Y. Prenatal management of disorders of sex development. J Pediatr Urol 2012;8:576-84.
43. Bianchi DW. Prepare for unexpected prenatal test results. Nature 2015; 522:29-30.